Concepedia

Susan O’Brien

SO

49

Publications

7.6K

Citations

34

H-Index

1991

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of California, Irvine

Memorial Sloan Kettering Cancer Center

Quest Diagnostics (United States)

Dana-Farber Cancer Institute

Susan O’Brien is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and cancer research.

Top concepts

Publications per year

1991–2023

49

Publications

49

Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias

Moshe Talpaz, Neil P. Shah, Hagop M. Kantarjian et al. · New England Journal of Medicine · 2006 · 1.8K citations · Full text

Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL

Hagop M. Kantarjian, Francis J. Giles, Lydia Wunderle et al. · New England Journal of Medicine · 2006 · 1.3K citations · Full text

Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia

Hagop M. Kantarjian, Susan O’Brien, Terry L. Smith et al. · Journal of Clinical Oncology · 2000 · 788 citations

Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia

Hagop Kantarjian, Farhad Ravandi, Susan O’Brien et al. · Blood · 2010 · 391 citations · Full text

High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome–positive chronic phase chronic myeloid leukemia

Hagop M. Kantarjian, Moshe Talpaz, Susan O’Brien et al. · Blood · 2003 · 391 citations · Full text

Rows per page

1–5 of 49